发明名称 |
HEPATITIS C VIRUS INHIBITORS |
摘要 |
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: Q-G-A-L-B—W  (I), which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
|
申请公布号 |
US2011189129(A1) |
申请公布日期 |
2011.08.04 |
申请号 |
US201113013212 |
申请日期 |
2011.01.25 |
申请人 |
QIU YAO-LING;WANG CE;PENG XIAOWEN;YING LU;CAO HUI;OR YAT SUN |
发明人 |
QIU YAO-LING;WANG CE;PENG XIAOWEN;YING LU;CAO HUI;OR YAT SUN |
分类号 |
A61K38/21;A61K31/41;A61K31/4188;A61K31/4196;A61K31/422;A61K31/4245;A61K31/427;A61K31/439;A61K31/4439;A61K31/454;A61K31/496;A61K31/506;A61K31/5377;A61K31/675;A61K31/7056;A61K38/19;A61K39/12;A61P1/16;A61P31/12;A61P31/18;A61P37/04;C07D487/14;C12N7/04 |
主分类号 |
A61K38/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|